🇺🇸 FDA
Patent

US 9517275

Targeted therapy for the prevention of restenosis in the cardiovascular system

granted A61KA61K33/00A61K38/00

Quick answer

US patent 9517275 (Targeted therapy for the prevention of restenosis in the cardiovascular system) held by Northwestern University expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K33/00, A61K38/00, A61K47/66